(Q53222164)

12 May 2018

title

Squalene epoxidase (SQLE) promotes the growth and migration of the hepatocellular carcinoma cells. (English)

1 reference

12 May 2018

1 reference

Zhenghui Sui

1

1 reference

12 May 2018

Jiahua Zhou

series ordinal

2

1 reference

12 May 2018

Zhangjun Cheng

series ordinal

3

1 reference

12 May 2018

Penhua Lu

series ordinal

4

1 reference

12 May 2018

publication date

19 March 2015

1 reference

12 May 2018

published in

Tumor Biology

1 reference

12 May 2018

volume

36

1 reference

12 May 2018

issue

8

1 reference

12 May 2018

page(s)

6173-6179

1 reference

12 May 2018

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Mortality trend for liver cancer in a hyperendemic area of hepatitis C virus infection in southern Italy: join-point analysis and comparison with European and Italian data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Chronic hepatitis virus infection increases the risk of pancreatic cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Aberrant deleted in liver cancer-1 expression is associated with tumor metastasis and poor prognosis in urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Potential role of nonstatin cholesterol lowering agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Genome-wide analysis of pancreatic cancer using microarray-based techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

TAZ expression as a prognostic indicator in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Identification of genes differentially expressed in human primary lung squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Dysregulation of the mevalonate pathway promotes transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Functional characterization of the Xanthophyllomyces dendrorhous farnesyl pyrophosphate synthase and geranylgeranyl pyrophosphate synthase encoding genes that are involved in the synthesis of isoprenoid precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Effect of FR194738, a potent inhibitor of squalene epoxidase, on cholesterol metabolism in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3301-X

Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

12 December 2020

Isoprenoid enzyme systems of silkworm. I. Partial purification of isopentenyl pyrophosphate isomerase, farnesyl pyrophosphate synthetase, and geranylgeranyl pyrophosphate synthetase

1 reference

12 December 2020

Post-HMG CoA reductase regulation of cholesterol biosynthesis in normal human lymphocytes: Lanosten-3β-ol-32-al, a natural inhibitor

1 reference

12 December 2020

Cholesterol biosynthesis, peroxisomes and peroxisomal disorders: mevalonate kinase is not only deficient in Zellweger syndrome but also in rhizomelic chondrodysplasia punctata

1 reference

12 December 2020

10.1007/S13277-015-3301-X

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018